We are very pleased to inform you that our work entitled “Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation” was awarded the first prize at the 5th National Conference of ISETAT that was held at 21-23 September 2017 in Athens.